Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Tumor cell lysates as immunogenic sources for cancer vaccine design
Dendritic cells in cancer immunotherapy clinical trials: are we making progress?
Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go
Wilms‘ Tumor Gene 1 (WT1)–loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial
Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancer
Myeloid-derived suppressor cells in glioma
Dendritic cell-based immunotherapy in ovarian cancer
Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma
[Immunotherapy and hyperthermia for the treatment of patients with advanced or recurrent colorectal cancer]
Dendritic cell vaccine for recurrent high-grade gliomas in pediatric and adult subjects: clinical trial protocol
[The effect of immunotherapy and hyperthermia on patients with advanced or recurrent breast cancer]
Dendritic cells, inflammation, and breast cancer
Autologous dendritic cell based adoptive immunotherapy of patients with colorectal cancer-A phase I-II study
Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma
Dendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trials
Exploiting dendritic cells in the development of cancer vaccines
A review of dendritic cell therapy for cancer: progress and challenges
Immunotherapy for high-grade glioma: how to go beyond Phase I/II clinical trials
Temperature matters! And why it should matter to tumor immunologists
Vaccination with dendritic cell-tumor fusion cells in multiple myeloma patients: a promising strategy?